Developer docs
API playgroundTry for free, no card

Search company profiles

Tribal Diagnostics

Full company profile

uuid0003pc4

Namestring
Tribal Diagnostics
Legal namestring
Tribal Diagnostics, LLC
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Tribal Diagnostics is a full-service CAP- and CLIA-accredited clinical laboratory headquartered in Oklahoma City, founded in October 2015 by Cory Littlepage, a citizen of the Chickasaw Nation. The laboratory operates as a high-complexity reference lab offering more than 1,000 diagnostic tests across diabetes, heart disease, substance abuse, infectious disease, and general health categories, with stated capabilities including serology (Abbott ARCHITECT platform, ~100 specimens/hour) and molecular PCR testing (ThermoFisher QuantStudio, ~200 specimens/day). Its technology footprint includes EMR interface capabilities with Indian Health Service systems, a patient portal (Luminate Health), a provider portal, an online billing portal, and text-based result notification ("text 'Tribal' to 66349").

The company pursues a sales-led go-to-market targeting tribal health systems (I/T/U facilities), private practice physicians, and rural healthcare providers via territory managers and a New Customer Request Form on its website. Revenue is generated on a transaction-fee basis through in-network contracts with the largest U.S. insurance carriers (Aetna, Cigna, Humana, UnitedHealthcare, 23 Blue Cross Blue Shield plans, Medicare, and Medicaid), supplemented by direct self-pay pricing set at Medicare-like rates (e.g., $5 for a cholesterol test, $9 for CBC, $13 for CMP). Approximately 80% of business comes from non-native/non-government clients, with the remaining minority directed to tribal facilities. Other revenue-adjacent offerings include an AI-powered RestoreU Dementia Panel launched October 2023 in partnership with uMETHOD Health. Operational scale includes over 140 employees, 2,500+ healthcare clients, 28 tribal health system partnerships, 697 healthcare clinics supported, and more than 6 million tests conducted since inception.

In April 2025 the company expanded from a 5,000 sq ft lab to a nearly 25,000 sq ft state-of-the-art facility, funded in part by a $3.2 million investment from Raven Indigenous Capital Partners in July 2023. In May 2026, Labcorp (a global laboratory services leader) acquired Tribal Diagnostics, transitioning the company from independent operation to subsidiary status.

Short descriptiontext

Tribal Diagnostics is a CAP-accredited clinical laboratory in Oklahoma City offering 1,000+ diagnostic tests at transparent Medicare-like pricing to tribal health systems, private healthcare providers, and self-pay patients, with nationwide in-network insurance access and acquisition by Labcorp in May 2026.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOklahoma City, United States
HQ citystring
Oklahoma City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory services, diagnostic testing services, medical reference laboratory, healthcare diagnostic solutions, pathology laboratory testing
Industry2 codes
1Reference & Esoteric Testing Laboratories
CodeHLAFAMAJPrimaryYes
2Tribal/Indigenous Public Health Authorities
CodeHLAJAAADPrimaryNo
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Diagnostic Laboratory Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Laboratory Testing Services
TypeTransaction Fee
Description

Revenue generated from clinical laboratory testing services billed to insurance carriers, Medicare/Medicaid, and direct patient payments. Test categories include diabetes, heart disease, substance abuse, infectious disease, and COVID-19 testing.

tribaldiagnostics.com
2Insurance Reimbursement
TypeTransaction Fee
Description

In-network laboratory contracted with major insurers including Aetna, Cigna, Humana, UnitedHealthcare, Medicare, Blue Cross Blue Shield plans, Molina, Centene, and Medicaid plans. Reimbursement rates negotiated through insurance contracts.

tribaldiagnostics.com
3Direct Patient Payment
TypeTransaction Fee
Description

Affordable self-pay pricing for uninsured or underinsured patients. Transparent pricing at Medicare-like rates with financial hardship assistance available.

tribaldiagnostics.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Self-pay transparent pricing for uninsured patients
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Cholesterol test: $5, Complete Blood Count (CBC): $9, Comprehensive Metabolic Panel (CMP): $13. Medicare-like rates for all services.

tribaldiagnostics.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Tribal Diagnostics is a full-service, CAP-accredited clinical laboratory that performs diagnostic testing for healthcare providers across the United States, with a particular focus on underserved and Native American communities. The laboratory offers over 1,000 tests spanning diabetes, heart disease, substance abuse, infectious disease, COVID-19, and general wellness panels at transparent Medicare-like rates. Services are delivered through provider partnerships, in-network insurance contracts with major carriers, and direct self-pay options to patients.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Tribal Diagnostics operates as a full-service CAP-accredited clinical laboratory with a unified core offering of over 1,000 laboratory tests spanning diabetes, heart disease, substance abuse, infectious disease, and general health panels. The company offers its testing services alongside a suite of patient and provider-facing digital portals (Patient Results Portal, Provider Portal, Patient Billing Portal) that extend the core lab testing product. Specialized offerings include COVID-19 testing and the RestoreU Dementia Panel, an AI-powered cognitive care planning module developed in partnership with uMETHOD Health.

Product and service3 records
1Clinical Laboratory Testing Services
CategoryCore Diagnostic Laboratory Services
Description

Full-service CAP-accredited clinical laboratory offering over 1,000 diagnostic tests including panels for diabetes, heart disease, substance abuse, infectious disease, COVID-19, and general health markers at transparent Medicare-like pricing ($5 cholesterol, $9 CBC, $13 CMP). Serves tribal and non-tribal healthcare providers with EMR interface capabilities and personalized service.

2COVID-19 Testing
CategorySpecialized Diagnostic Testing
Description

Coronavirus testing services including serology/antibody tests using the Abbott ARCHITECT instrument (100 specimens/hour) and nasal swab PCR molecular tests using the ThermoFisher QuantStudio instrument (200 specimens/day), priced at Medicare rates. Made available to I/T/U facilities and other healthcare providers.

3RestoreU Dementia Panel
CategorySpecialty Diagnostic Panel
Description

AI-powered risk assessment and care plan service for Alzheimer's and dementia, developed in partnership with uMETHOD Health. Analyzes 50+ risk factors from lab results and health history to generate personalized, evidence-based care plans for physicians managing cognitive decline.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeOthersAnnounced on2026-05-01
Description

Global leader in innovative and comprehensive laboratory services has acquired Tribal Diagnostics, announced on company website.

2Gary Huff
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-01
Description

Former CEO of Labcorp Diagnostics with over three decades of experience in diagnostics industry. Joined Board of Directors to provide deep industry knowledge and guide company expansion across Oklahoma, Texas, and Louisiana.

tribaldiagnostics.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-08-01
Description

General Partner at Raven Indigenous Capital Partners and member of Gitxsan First Nation. Joined Board of Directors to provide venture capital expertise and support health-focused companies.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major national insurance carrier with nationwide contract for laboratory services, providing access to millions of insured members.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major national insurance carrier contracted for in-network laboratory services.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major national insurance carrier contracted for in-network laboratory services.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major national insurance carrier contracted for in-network laboratory services.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

23 Blue Cross Blue Shield plans contracted nationwide for in-network laboratory services.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

National physicians association providing letter of support for Tribal Diagnostics. MIP supports tribal health initiatives and recognizes Tribal Diagnostics as a valued partner and collaborator.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of the two largest U.S. clinical reference laboratories, offering a full menu of diagnostic tests nationwide. Directly comparable to Tribal Diagnostics in core service offering but operates at vastly larger scale across all customer segments including underserved populations.

TypeBroad incumbent
Description

Global leader in clinical laboratory services and now parent of Tribal Diagnostics following the May 2026 acquisition. Directly comparable core business of clinical reference lab testing across the U.S.

TypeBroad incumbent
Description

Major U.S. clinical reference laboratory operator with regional and esoteric testing capabilities. Comparable to Tribal Diagnostics as a multi-state clinical lab serving healthcare providers with a broad test menu.

TypeDirect peer
Description

National reference and esoteric testing laboratory affiliated with the University of Utah. Comparable to Tribal Diagnostics as a CAP-accredited high-complexity clinical laboratory serving healthcare providers nationwide.

TypeDirect peer
Description

Reference laboratory arm of Mayo Clinic offering specialized and routine clinical testing to hospitals and providers globally. Comparable to Tribal Diagnostics in serving healthcare providers with high-complexity clinical testing.

TypeDirect peer
Description

Specialty clinical laboratory focused on infectious disease PCR and molecular testing for providers. Comparable to Tribal Diagnostics in clinical lab operations targeting underserved provider segments, with overlap in molecular diagnostics capabilities.

TypeDirect peer
Description

Specialty clinical laboratory offering esoteric and infectious disease testing to healthcare providers. Comparable to Tribal Diagnostics in clinical reference lab services, particularly in specialty/serology testing categories.

TypeDirect peer
Description

Direct-to-consumer walk-in retail lab testing franchise with transparent self-pay pricing. Comparable to Tribal Diagnostics in offering transparent, affordable lab testing and operating patient service centers.

TypeOthers
Description

Indigenous-focused venture capital investor and prior $3.2M backer of Tribal Diagnostics. Comparable in the sense of being a capital partner aligned with Native-led businesses operating in Indian Country.

TypeOthers
Description

AI-powered personalized medicine platform partnering with Tribal Diagnostics on the RestoreU Dementia Panel. Comparable as a technology collaborator enabling specialty diagnostic offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Tribal Diagnostics

Clinical Diagnostic Laboratory Servicestribaldiagnostics.com

Tribal Diagnostics is a CAP-accredited clinical laboratory in Oklahoma City offering 1,000+ diagnostic tests at transparent Medicare-like pricing to tribal health systems, private healthcare providers, and self-pay patients, with nationwide in-network insurance access and acquisition by Labcorp in May 2026.

What Tribal Diagnostics does

Tribal Diagnostics is a full-service CAP- and CLIA-accredited clinical laboratory headquartered in Oklahoma City, founded in October 2015 by Cory Littlepage, a citizen of the Chickasaw Nation. The laboratory operates as a high-complexity reference lab offering more than 1,000 diagnostic tests across diabetes, heart disease, substance abuse, infectious disease, and general health categories, with stated capabilities including serology (Abbott ARCHITECT platform, ~100 specimens/hour) and molecular PCR testing (ThermoFisher QuantStudio, ~200 specimens/day). Its technology footprint includes EMR interface capabilities with Indian Health Service systems, a patient portal (Luminate Health), a provider portal, an online billing portal, and text-based result notification ("text 'Tribal' to 66349").

The company pursues a sales-led go-to-market targeting tribal health systems (I/T/U facilities), private practice physicians, and rural healthcare providers via territory managers and a New Customer Request Form on its website. Revenue is generated on a transaction-fee basis through in-network contracts with the largest U.S. insurance carriers (Aetna, Cigna, Humana, UnitedHealthcare, 23 Blue Cross Blue Shield plans, Medicare, and Medicaid), supplemented by direct self-pay pricing set at Medicare-like rates (e.g., $5 for a cholesterol test, $9 for CBC, $13 for CMP). Approximately 80% of business comes from non-native/non-government clients, with the remaining minority directed to tribal facilities. Other revenue-adjacent offerings include an AI-powered RestoreU Dementia Panel launched October 2023 in partnership with uMETHOD Health. Operational scale includes over 140 employees, 2,500+ healthcare clients, 28 tribal health system partnerships, 697 healthcare clinics supported, and more than 6 million tests conducted since inception.

In April 2025 the company expanded from a 5,000 sq ft lab to a nearly 25,000 sq ft state-of-the-art facility, funded in part by a $3.2 million investment from Raven Indigenous Capital Partners in July 2023. In May 2026, Labcorp (a global laboratory services leader) acquired Tribal Diagnostics, transitioning the company from independent operation to subsidiary status.

Tribal Diagnostics firmographics

Firmographics
Name
Tribal Diagnostics
Legal name
Tribal Diagnostics, LLC
Website
https://tribaldiagnostics.com
Company type
Private
Founded year
2015
Operating status
Acquired
Headcount range
11–50 employees
Short description
Tribal Diagnostics is a CAP-accredited clinical laboratory in Oklahoma City offering 1,000+ diagnostic tests at transparent Medicare-like pricing to tribal health systems, private healthcare providers, and self-pay patients, with nationwide in-network insurance access and acquisition by Labcorp in May 2026.
Ownership category
akta.pro rank

Tribal Diagnostics industry classification

Industry
Product category
Clinical Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Reference & Esoteric Testing Laboratories (HLAFAMAJ)
akta.pro secondary industry
Tribal/Indigenous Public Health Authorities (HLAJAAAD)

Keywords

  • Clinical laboratory services
  • Diagnostic testing services
  • Medical reference laboratory
  • Healthcare diagnostic solutions
  • Pathology laboratory testing

Where Tribal Diagnostics is headquartered

Location

Headquarters

HQ city
Oklahoma City
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Tribal Diagnostics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

  1. Laboratory Testing Services: Revenue generated from clinical laboratory testing services billed to insurance carriers, Medicare/Medicaid, and direct patient payments. Test categories include diabetes, heart disease, substance abuse, infectious disease, and COVID-19 testing.
  2. Insurance Reimbursement: In-network laboratory contracted with major insurers including Aetna, Cigna, Humana, UnitedHealthcare, Medicare, Blue Cross Blue Shield plans, Molina, Centene, and Medicaid plans. Reimbursement rates negotiated through insurance contracts.
  3. Direct Patient Payment: Affordable self-pay pricing for uninsured or underinsured patients. Transparent pricing at Medicare-like rates with financial hardship assistance available.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goSelf-pay transparent pricing for uninsured patients

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Tribal Diagnostics product offering

Product offering

Core offering

Tribal Diagnostics is a full-service, CAP-accredited clinical laboratory that performs diagnostic testing for healthcare providers across the United States, with a particular focus on underserved and Native American communities. The laboratory offers over 1,000 tests spanning diabetes, heart disease, substance abuse, infectious disease, COVID-19, and general wellness panels at transparent Medicare-like rates. Services are delivered through provider partnerships, in-network insurance contracts with major carriers, and direct self-pay options to patients.

Product overview

Tribal Diagnostics operates as a full-service CAP-accredited clinical laboratory with a unified core offering of over 1,000 laboratory tests spanning diabetes, heart disease, substance abuse, infectious disease, and general health panels. The company offers its testing services alongside a suite of patient and provider-facing digital portals (Patient Results Portal, Provider Portal, Patient Billing Portal) that extend the core lab testing product. Specialized offerings include COVID-19 testing and the RestoreU Dementia Panel, an AI-powered cognitive care planning module developed in partnership with uMETHOD Health.

Differentiator

Problem solved

Functional benefit

Products and services

  • Clinical Laboratory Testing Services Full-service CAP-accredited clinical laboratory offering over 1,000 diagnostic tests including panels for diabetes, heart disease, substance abuse, infectious disease, COVID-19, and general health markers at transparent Medicare-like pricing ($5 cholesterol, $9 CBC, $13 CMP). Serves tribal and non-tribal healthcare providers with EMR interface capabilities and personalized service.
  • COVID-19 Testing Coronavirus testing services including serology/antibody tests using the Abbott ARCHITECT instrument (100 specimens/hour) and nasal swab PCR molecular tests using the ThermoFisher QuantStudio instrument (200 specimens/day), priced at Medicare rates. Made available to I/T/U facilities and other healthcare providers.
  • RestoreU Dementia Panel AI-powered risk assessment and care plan service for Alzheimer's and dementia, developed in partnership with uMETHOD Health. Analyzes 50+ risk factors from lab results and health history to generate personalized, evidence-based care plans for physicians managing cognitive decline.

Companies that use Tribal Diagnostics

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Tribal Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Tribal Diagnostics partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • LabcorpcoreOthers · 1 May 2026Global leader in innovative and comprehensive laboratory services has acquired Tribal Diagnostics, announced on company website.
  • Gary HuffcoreStrategic or Co-development Partner · 1 April 2025Former CEO of Labcorp Diagnostics with over three decades of experience in diagnostics industry. Joined Board of Directors to provide deep industry knowledge and guide company expansion across Oklahoma, Texas, and Louisiana.
  • Althea WishloffcoreStrategic or Co-development Partner · 1 August 2024General Partner at Raven Indigenous Capital Partners and member of Gitxsan First Nation. Joined Board of Directors to provide venture capital expertise and support health-focused companies.
  • United HealthcarecoreChannel Partner/ Reseller/ DistributorMajor national insurance carrier with nationwide contract for laboratory services, providing access to millions of insured members.
  • CignacoreChannel Partner/ Reseller/ DistributorMajor national insurance carrier contracted for in-network laboratory services.
  • AetnacoreChannel Partner/ Reseller/ DistributorMajor national insurance carrier contracted for in-network laboratory services.
  • HumanacoreChannel Partner/ Reseller/ DistributorMajor national insurance carrier contracted for in-network laboratory services.
  • Blue Cross Blue Shield Plans (23 plans)coreChannel Partner/ Reseller/ Distributor23 Blue Cross Blue Shield plans contracted nationwide for in-network laboratory services.
  • Association of American Indian Physicians (AAIP)minorStrategic or Co-development PartnerNational physicians association providing letter of support for Tribal Diagnostics. MIP supports tribal health initiatives and recognizes Tribal Diagnostics as a valued partner and collaborator.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Tribal Diagnostics competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: One of the two largest U.S. clinical reference laboratories, offering a full menu of diagnostic tests nationwide. Directly comparable to Tribal Diagnostics in core service offering but operates at vastly larger scale across all customer segments including underserved populations.
  • Labcorp: Global leader in clinical laboratory services and now parent of Tribal Diagnostics following the May 2026 acquisition. Directly comparable core business of clinical reference lab testing across the U.S.
  • Sonic Healthcare USA (Clinical Pathology Laboratories): Major U.S. clinical reference laboratory operator with regional and esoteric testing capabilities. Comparable to Tribal Diagnostics as a multi-state clinical lab serving healthcare providers with a broad test menu.

Direct peers

  • ARUP Laboratories: National reference and esoteric testing laboratory affiliated with the University of Utah. Comparable to Tribal Diagnostics as a CAP-accredited high-complexity clinical laboratory serving healthcare providers nationwide.
  • Mayo Clinic Laboratories: Reference laboratory arm of Mayo Clinic offering specialized and routine clinical testing to hospitals and providers globally. Comparable to Tribal Diagnostics in serving healthcare providers with high-complexity clinical testing.
  • HealthTrackRx: Specialty clinical laboratory focused on infectious disease PCR and molecular testing for providers. Comparable to Tribal Diagnostics in clinical lab operations targeting underserved provider segments, with overlap in molecular diagnostics capabilities.
  • Eurofins Viracor: Specialty clinical laboratory offering esoteric and infectious disease testing to healthcare providers. Comparable to Tribal Diagnostics in clinical reference lab services, particularly in specialty/serology testing categories.
  • AnyLabTestNow: Direct-to-consumer walk-in retail lab testing franchise with transparent self-pay pricing. Comparable to Tribal Diagnostics in offering transparent, affordable lab testing and operating patient service centers.

Others

  • Raven Indigenous Capital Partners: Indigenous-focused venture capital investor and prior $3.2M backer of Tribal Diagnostics. Comparable in the sense of being a capital partner aligned with Native-led businesses operating in Indian Country.
  • uMETHOD Health: AI-powered personalized medicine platform partnering with Tribal Diagnostics on the RestoreU Dementia Panel. Comparable as a technology collaborator enabling specialty diagnostic offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Tribal Diagnostics social profiles

Digital presence

Tribal Diagnostics compliance and trust

Trust signal

Compliance2 records

Tribal Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tribal Diagnostics leadership team

Management profile

Number of profiles

Profiles9 records

Tribal Diagnostics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tribal Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tribal Diagnostics

What does Tribal Diagnostics do?

Tribal Diagnostics is a full-service, CAP-accredited clinical laboratory that performs diagnostic testing for healthcare providers across the United States, with a particular focus on underserved and Native American communities. The laboratory offers over 1,000 tests spanning diabetes, heart disease, substance abuse, infectious disease, COVID-19, and general wellness panels at transparent Medicare-like rates. Services are delivered through provider partnerships, in-network insurance contracts with major carriers, and direct self-pay options to patients.

Is Tribal Diagnostics a public or private company?

Tribal Diagnostics is a private company. It is classified as corporate owned and is currently acquired.

When was Tribal Diagnostics founded?

Tribal Diagnostics was founded in 2015. It employs 11 to 50 people.

Where is Tribal Diagnostics based?

Tribal Diagnostics is headquartered in Oklahoma City, United States, in the North America region.

How does Tribal Diagnostics make money?

Three revenue lines are on record. Laboratory Testing Services are the primary driver. The others are insurance Reimbursement and direct Patient Payment.

Who are Tribal Diagnostics's main competitors?

Broad incumbents on record are Quest Diagnostics, Labcorp and Sonic Healthcare USA (Clinical Pathology Laboratories). Direct peers are ARUP Laboratories, Mayo Clinic Laboratories, HealthTrackRx, Eurofins Viracor and AnyLabTestNow. Others are Raven Indigenous Capital Partners and uMETHOD Health.

Does Tribal Diagnostics have an API?

No public API is recorded for Tribal Diagnostics.

What industry is Tribal Diagnostics in?

Tribal Diagnostics's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories, with a secondary code of HLAJAAAD, Tribal/Indigenous Public Health Authorities. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Motley FoolLabcorp (LH) Q2 2026 Earnings Call TranscriptLabcorp Holdings Inc. reported second-quarter 2026 results with enterprise revenue of $3.7 billion, up 5.8% year-over-year, driven by 4.2% organic growth and 1.2% contribution from net acquisitions, alongside adjusted EPS of $4.99, up 14.9%, and adjusted operating margin expansion of 70 basis points to 15.8%. The company raised its full-year revenue guidance to 5.4%-6.3% growth and adjusted EPS guidance to $18.10-$18.55, citing strength across specialty testing segments including oncology, neurology, autoimmune disease, and women's health, which delivered double-digit revenue growth in the first half. Key strategic developments include the nationwide launch of ColoSense as the first FDA-approved RNA-based colorectal cancer screening test with at-home collection, completion of acquisitions including Parkview Health outreach lab services and Tribal Diagnostics, and expanded collaboration with Epic making over 6,500 diagnostic tests accessible on the Epic Aura platform.AdvfnLabcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 GuidanceLabcorp Holdings Inc. announced second quarter 2026 results with revenue of $3.73 billion, up 5.8% year-over-year, driven by growth in both its Diagnostics Laboratories and Biopharma Laboratory Services segments. The company reported diluted EPS of $3.64 and adjusted EPS of $4.99, representing increases of 28.5% and 14.9% respectively, while raising its full-year revenue growth guidance to 5.4%–6.3% and adjusted EPS guidance to $18.10–$18.55. Labcorp also increased its share repurchase authorization by $1.0 billion to $1.4 billion and completed acquisitions including select outreach laboratory services from Parkview Health and Tribal Diagnostics.MorningstarLabcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 GuidanceLabcorp Holdings Inc. reported second quarter 2026 revenue of $3.73 billion, up 5.8% year-over-year, with diluted EPS of $3.64 and adjusted EPS of $4.99, representing 28.5% and 14.9% growth respectively. The company raised its full-year 2026 revenue growth guidance to 5.4%-6.3% and adjusted EPS guidance to $18.10-$18.55, while also increasing its share repurchase authorization by $1.0 billion to $1.4 billion remaining. Labcorp advanced its oncology offerings during the quarter, launching ColoSense as the first FDA-approved RNA-based colorectal cancer screening test with at-home collection and completing $225.7 million in acquisitions including select outreach laboratory services from Parkview Health and Tribal Diagnostics.PR NewswireLabcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 GuidanceLabcorp Holdings Inc. announced second quarter 2026 results with revenue of $3.73 billion, up 5.8% year-over-year, and adjusted EPS of $4.99, up 14.9% from the prior year period. The company raised its full-year revenue growth guidance to 5.4%-6.3% and adjusted EPS guidance to $18.10-$18.55, while also increasing its share repurchase authorization by $1.0 billion to $1.4 billion remaining. Labcorp completed two acquisitions during the quarter—select outreach laboratory services from Parkview Health and Tribal Diagnostics—investing $225.7 million in acquisitions total.Community ImpactTribal Diagnostics offers clinical laboratory services in New BraunfelsTribal Diagnostics opened its New Braunfels Patient Service Center in April at 2163 Stephens Place, Ste. 103. The privately owned lab, created in 2016, offers CAP-accredited clinical services and is in-network with major carriers. It also cites cost and customer service as differentiators.MVSKOKE MediaIndigenous-owned clinical laboratory opens new location in OklahomaTribal Diagnostics officially opened a new, 25,000-square-foot clinical laboratory location in south Oklahoma City on April 14, marking a fivefold expansion from its previous facility. The upgraded center will provide over 1,000 types of lab tests and sample transport services to support the detection of critical diseases within underserved Native American communities across Oklahoma and Texas. This expansion aims to improve healthcare access and diagnostic capabilities for Indigenous populations through partnerships with 28 tribal health systems.PR NewswireTribal Diagnostics Announces Availability of Personalized Alzheimer's and Dementia Care Plans Via Partnership with uMETHOD HealthTribal Diagnostics, a high-complexity diagnostics laboratory, has announced the availability of the RestoreU Dementia Panel in Texas and Oklahoma through a partnership with uMETHOD Health, a health technology company specializing in precision medicine. The RestoreU service uses assistive AI to analyze over 50 risk factors from lab results and patient health history to generate personalized, evidence-based care plans for individuals with Alzheimer's and dementia. The partnership aims to help physicians close care gaps for patients with cognitive decline while satisfying cognitive care guidelines, with disease-modifying Alzheimer's treatments now available for clinical care for the first time.Pulse 2.0Tribal Diagnostics: Native American-Owned Medical Diagnostics Company Raises $3.2 MillionTribal Diagnostics, a Native American-owned medical diagnostics laboratory, has secured a $3.2 million investment from Raven Indigenous Capital Partners to expand its services and reach more clients in Indian Country. This funding aims to facilitate growth into new markets, drive lab service innovations, and increase hiring, aligning with both companies' commitments to improving healthcare outcomes in Indigenous communities. Raven has ambitious plans to invest over $30 million into Native-owned businesses over the next three years, reflecting a focus on building a robust Native American economy in the US.FinSMEsTribal Diagnostics Receives USD$3.2M From Raven Indigenous Capital PartnersTribal Diagnostics secured a $3.2 million investment from Raven Indigenous Capital Partners to support expansion into new markets and service innovations. The Oklahoma City-based laboratory, led by CEO Cory Littlepage, provides diagnostic testing for conditions such as diabetes and heart disease to tribal and non-tribal providers.SecSEC FORM DTribal Diagnostics Inc. filed a Form D with the Securities and Exchange Commission to report an exempt offering of equity securities under Rule 506(b). The filing indicates that $3,200,000 USD was raised from one investor, with the first sale occurring on June 16, 2023. The company is based in Oklahoma City, Delaware.